Corbus Pharmaceuticals Holdings, Inc

(NASDAQ:CRBP)

Latest On Corbus Pharmaceuticals Holdings, Inc (CRBP):

Date/Time Type Description Signal Details
2022-11-08 10:30 ESTNewsCorbus Pharmaceuticals GAAP EPS of -$0.07 misses by $0.01N/A
2022-08-09 22:16 ESTNewsCorbus Pharmaceuticals GAAP EPS of -$0.11N/A
2022-05-11 02:18 ESTNewsCorbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01N/A
2022-03-08 11:50 ESTNewsCorbus Pharmaceuticals GAAP EPS of -$0.37 beats by $0.03, revenue of $0.88M beats by $0.04MN/A
2021-11-12 19:24 ESTNewsCorbus Pharmaceuticals EPS beats by $0.10, misses on revenueN/A
2021-07-21 03:17 ESTNewsCorbus Pharma gains 9% on licensing deal for monoclonal antibodies in cancer and fibrotic diseasesN/A
2021-07-21 03:15 ESTNewsCorbus Pharmaceuticals (CRBP) Investor Presentation - SlideshowN/A
2021-07-21 03:01 ESTNewsSTSA, AXLA, CVAC and CRBP among after-hours moversN/A
2021-07-21 02:55 ESTNewsCorbus Pharma hurt by setback in late-stage trial for rare autoimmune diseaseN/A
2021-04-20 22:08 ESTNewsCorbus completes enrollment in mid-stage autoimmune disease trialN/A
2021-04-15 18:01 ESTNewsCorbus: Assessing If Lenabasum Can Finally Break ThroughN/A
2021-03-30 23:42 ESTNewsCorbus gives update on late-stage lenabasum trial progressN/A
2021-03-18 04:27 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 21:09 ESTNewsCorbus Pharmaceuticals Holdings, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-17 12:26 ESTAnalyst RatingThe Analyst Target Price has increased from $2.02 to $2.23.Buy
2021-03-16 22:27 ESTNewsCorbus Pharmaceuticals EPS beats by $0.13, misses on revenueN/A
2021-03-16 22:27 ESTNewsCorbus hints at potential pipeline expansion deals, shares riseN/A
2021-03-16 22:26 ESTNewsCorbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-16 20:33 ESTEarnings EstimateAn EPS average of -$0.86 is estimated for the 2022 year.Sell
2021-03-16 20:33 ESTEarnings EstimateAn EPS average of -$0.13 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-16 20:33 ESTAnalyst RatingThe Analyst Target Price has increased from $1.88 to $2.02.Neutral
2021-03-05 17:49 ESTNewsSeeking Alpha Catalyst WatchN/A
2021-02-06 16:40 ESTNewsMarijuana as medicine: the other cannabinoid pharma playersN/A
2021-02-03 00:04 ESTNewsINO, VXRT, BTU and TTM among premarket gainersN/A
2021-01-29 16:16 ESTNewsCorbus Pharmaceuticals: Down But Not OutN/A
2021-01-11 11:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.9 to $1.88.Neutral
2020-12-13 03:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 03:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 16:26 ESTNewsCorbus Pharmaceuticals Holdings, Inc. (CRBP) CEO Yuval Cohen on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-11 03:31 ESTEarnings EstimateAn EPS average of -$0.26 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-10 10:45 ESTNewsCorbus's lenabasum shows benefit in autoimmune disorderN/A
2020-11-10 10:45 ESTNewsLenabasum Exposure Wipes Shareholder Upside For Corbus PharmaceuticalsN/A
2020-11-10 10:45 ESTNewsCorbus Pharmaceutical (CRBP) Phase 3 data lenabasum in systemic sclerosis - SlideshowN/A
2020-11-10 10:43 ESTNewsCorbus Pharmaceuticals down 4% after Q2 miss; top-line down 52%N/A
2020-11-10 10:43 ESTNewsCorbus Pharmaceuticals Holdings, Inc.'s (CRBP) CEO Yuval Cohen On Q3 2020 Results - Quick Version Earnings Call TranscriptN/A
2020-11-07 15:29 ESTFinancialsCompany financials have been released.Neutral
2020-10-23 23:06 ESTNewsAbnormality in control group flagged as possible reason for failed study of Corbus Pharma's lenabasumN/A
2020-10-13 12:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $6.9.Neutral
2020-10-08 20:40 ESTNewsCorbus Pharma to ax 54% of workforce in cost-cutting moveN/A
2020-10-08 16:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.74 to $7.5.Neutral
2020-10-07 16:39 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.3 to $7.74.Neutral
2020-10-07 15:04 ESTNewsRoth Capital cuts target price for Corbus PharmaceuticalsN/A
2020-10-06 08:11 ESTNewsCorbus Pharma's lenabasum flunks mid-stage cystic fibrosis study; shares down 30%N/A
2020-09-26 12:26 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 08:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.75 to $8.3.Neutral
2020-09-09 12:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $25.14 to $13.75.Neutral
2020-09-08 10:14 ESTNewsCorbus Pharma's lenabasum flunks late-stage systemic sclerosis study, shares down 77%N/A
2020-09-05 00:30 ESTFinancialsCompany financials have been released.Neutral
2020-08-21 20:33 ESTNewsCorbus Pharmaceuticals: Ultra High Implied Volatility Brings OpportunityN/A

About Corbus Pharmaceuticals Holdings, Inc (CRBP):

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic oral endocannabinoid drug that is in Phase III clinical trials for the treatment of systemic sclerosis and dermatomyositis, and in Phase IIb clinical trials to treat systemic lupus erythematosus and cystic fibrosis. The company is also developing CRB-4001, a peripherally-restricted CB1 inverse agonist, for nonalcoholic steatohepatitis and other fibrotic diseases. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was founded in 2009 and is based in Norwood, Massachusetts.

CRBP Quotes by TradingView

See Advanced Chart

General

  • Name Corbus Pharmaceuticals Holdings, Inc
  • Symbol CRBP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 76
  • Fiscal Year EndDecember
  • IPO Date2014-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.corbuspharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 44.06
  • Price/Book (Most Recent Quarter) 6.13
  • Enterprise Value Revenue 55.56
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.51
  • Next Year EPS Estimate -$0.47
  • Next Quarter EPS Estimate -$0.15
  • Operating Margin -3119%
  • Return on Assets -101%
  • Return on Equity -433%
  • Revenue 3.94 million
  • Earnings Per Share -$0.93
  • Revenue Per Share $0.05
  • Gross Profit -94329983
  • Quarterly Earnings Growth -74.4%
View More

Highlights

  • Market Capitalization 269.86 million
  • EBITDA -56710588
  • PE Ratio -16.14
  • Analyst Target Price $2.23
  • Book Value Per Share $0.46
View More

Share Statistics

  • Shares Outstanding 124.94 million
  • Shares Float 115.36 million
  • % Held by Insiders 173%
  • % Held by Institutions 75.49%
  • Shares Short 13.58 million
  • Shares Short Prior Month 22.14 million
  • Short Ratio 0.52
  • Short % of Float 20%
  • Short % of Shares Outstanding 16%
View More

Technicals

  • Beta 2
  • 52 Week High $9.78
  • 52 Week Low $0.91
  • 50 Day Moving Average 2.48
  • 200 Day Moving Average 1.98
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Corbus Pharmaceuticals Holdings, Inc (CRBP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Corbus Pharmaceuticals Holdings, Inc (CRBP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-15$658204-$0.10-$0.2560%
2020-09-302020-11-09$N/A-$0.43-$0.41-5.91%
2020-06-302020-08-06$N/A-$0.52-$0.38-38.67%
2020-03-312020-05-11$1.76 million-$0.43-$0.42-1.58%
2019-12-312020-03-12$2.57 million-$0.41-$0.36-14.53%
2019-09-302019-11-07$2.59 million-$0.32-$0.3611.92%
2019-06-302019-08-08$29.09 million$0.03-$0.36108.43%
2019-03-312019-05-09$1.89 million-$0.43-$0.15-189.95%
2018-12-312019-03-12$1.93 million-$0.31-$0.27-16.24%
2018-09-302018-11-08$1.09 million-$0.26-$0.22-17.28%
2018-06-302018-08-08$853646-$0.21-$0.222.33%
2018-03-312018-05-10$950442-$0.21-$0.15-44.83%
2017-12-312018-03-12$1.64 million-$0.21-$0.15-36.36%
2017-09-302017-11-08$796000-$0.14-$0.1612.5%
2017-06-302017-08-09$350000-$0.15-$0.1919.66%
2017-03-312017-05-09$1.29 million-$0.16-$0.160%
2016-12-312017-03-08$375000-$0.18-$0.14-31.68%
2016-09-302016-11-10$743000-$0.12-$0.11-9.09%
2016-06-302016-08-12$396000-$0.11-$0.08-46.67%
2016-03-312016-05-13$397000-$0.08-$0.080%
2015-12-312016-03-28$364000-$0.06-$0.0717.24%
2015-09-302015-11-11$170000-$0.06-$0.0825%
2015-06-302015-08-13$114000-$0.10
2015-03-312015-05-13$N/A-$0.06
2014-12-312015-02-10$N/A-$0.05

Corbus Pharmaceuticals Holdings, Inc (CRBP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Corbus Pharmaceuticals Holdings, Inc (CRBP) Chart:

CRBP chart by TradingView

Corbus Pharmaceuticals Holdings, Inc (CRBP) News:

Below you will find a list of latest news for Corbus Pharmaceuticals Holdings, Inc (CRBP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Corbus Pharmaceuticals Holdings, Inc (CRBP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-202.50CALL0 0609.73TRUE00
2025-06-2054CALL1 8667.84TRUE40
2025-06-207.51.8CALL33 6384.36TRUE0.280.18
2025-06-20100.34CALL210 39189.84FALSE0.140.7
2025-06-2012.50CALL0 19198.71FALSE00
2025-06-20150.6CALL0 82222.38FALSE00
2025-06-2017.50CALL0 20547.34FALSE00
2025-06-20200CALL0 20319.02FALSE00
2025-06-2022.50CALL0 7372.39FALSE00
2025-06-20250CALL0 12580.3FALSE00
2025-06-20300CALL0 112629.67FALSE00
2025-06-20350CALL0 49480.07FALSE00
2025-06-202.50PUT0 70702.88FALSE00
2025-06-2050PUT0 37172.5FALSE00
2025-06-207.50.2PUT0 13270.58FALSE00
2025-06-20100PUT0 1827.16TRUE00
2025-06-2012.53.6PUT11 11175.26TRUE3.60
2025-06-20150PUT0 0182.83TRUE00
2025-06-2017.50PUT0 0309.19TRUE00
2025-06-20200PUT0 0538.79TRUE00
2025-06-2022.50PUT0 0344.44TRUE00
2025-06-20250PUT0 0327.13TRUE00
2025-06-20300PUT0 0369.45TRUE00
2025-06-20350PUT0 0451.81TRUE00
2025-07-182.50CALL0 0407.18TRUE00
2025-07-1850CALL0 0221.15TRUE00
2025-07-187.50CALL0 1202.17TRUE00
2025-07-18100.4CALL0 5104.3FALSE00
2025-07-1812.50.2CALL0 1120.81FALSE00
2025-07-18150CALL0 0278.34FALSE00
2025-07-182.50PUT0 0958.47FALSE00
2025-07-1850PUT0 0444.91FALSE00
2025-07-187.50PUT0 0143.15FALSE00
2025-07-18100PUT0 063.1TRUE00
2025-07-1812.50PUT0 0173.46TRUE00
2025-07-18150PUT0 0166.22TRUE00
2025-09-192.55.98CALL0 1272.88TRUE00
2025-09-1954.4CALL101 12183.42TRUE4.40
2025-09-197.52.7CALL201 22993.23TRUE0.30.13
2025-09-19101.65CALL50 8697.24FALSE0.130.09
2025-09-1912.50CALL0 5688.93FALSE00
2025-09-19150.3CALL0 3996.61FALSE00
2025-09-1917.50.52CALL0 123119.74FALSE00
2025-09-19200CALL0 13131.81FALSE00
2025-09-1922.50.01CALL0 5193.46FALSE00
2025-09-192.50PUT0 53213.53FALSE00
2025-09-1950.35PUT0 10123.94FALSE00
2025-09-197.51.1PUT1 31107.27FALSE1.10
2025-09-19102.75PUT0 2090.43TRUE00
2025-09-1912.50PUT0 2101.45TRUE00
2025-09-19150PUT0 092.7TRUE00
2025-09-1917.50PUT0 0129.81TRUE00
2025-09-19200PUT0 0150.95TRUE00
2025-09-1922.50PUT0 0124.12TRUE00
2025-12-192.50CALL0 0175.18TRUE00
2025-12-1954.5CALL0 292.36TRUE00
2025-12-197.52.63CALL0 5691.93TRUE00
2025-12-19102.2CALL20 9490.52FALSE2.20
2025-12-1912.51.35CALL0 680.34FALSE00
2025-12-19150CALL0 0119.46FALSE00
2025-12-192.50PUT0 10336.96FALSE00
2025-12-1950PUT0 0120.48FALSE00
2025-12-197.50PUT0 1270.33FALSE00
2025-12-19100PUT0 2089.73TRUE00
2025-12-1912.50PUT0 093.9TRUE00
2025-12-19150PUT0 073.82TRUE00

Latest CRBP Trades:

Date Shares Price
Jun 13, 2022 6:21 PM EST267$0.2624
Jun 13, 2022 6:21 PM EST300$0.2624
Jun 13, 2022 6:23 PM EST50$0.2624
Jun 13, 2022 6:24 PM EST50$0.2624
Jun 13, 2022 6:24 PM EST50$0.2624

Corbus Pharmaceuticals Holdings, Inc (CRBP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm
2019-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595097/000000000019009641/0000000000-19-009641-index.htm
2019-07-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595097/000000000019011115/0000000000-19-011115-index.htm
2020-04-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595097/000000000020003171/0000000000-20-003171-index.htm
2020-10-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000009375120000967/0000093751-20-000967-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000021545719003233/0000215457-19-003233-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000083423720005448/0000834237-20-005448-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000090571819000212/0000905718-19-000212-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000110465920021777/0001104659-20-021777-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000114420419007532/0001144204-19-007532-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118033766/0001209191-18-033766-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118033770/0001209191-18-033770-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118033772/0001209191-18-033772-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118033781/0001209191-18-033781-index.htm
2018-06-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118035974/0001209191-18-035974-index.htm
2018-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118035975/0001209191-18-035975-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119004573/0001209191-19-004573-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119004574/0001209191-19-004574-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119004577/0001209191-19-004577-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119004579/0001209191-19-004579-index.htm
2019-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119015953/0001209191-19-015953-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119015958/0001209191-19-015958-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm
2019-04-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119023973/0001209191-19-023973-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119023975/0001209191-19-023975-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039459/0001209191-19-039459-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039463/0001209191-19-039463-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039465/0001209191-19-039465-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039467/0001209191-19-039467-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039468/0001209191-19-039468-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119039469/0001209191-19-039469-index.htm
2019-08-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045052/0001209191-19-045052-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045053/0001209191-19-045053-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120017383/0001209191-20-017383-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120017393/0001209191-20-017393-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120017400/0001209191-20-017400-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120017408/0001209191-20-017408-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120017413/0001209191-20-017413-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031658/0001209191-20-031658-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031659/0001209191-20-031659-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031660/0001209191-20-031660-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031661/0001209191-20-031661-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031662/0001209191-20-031662-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000120919120031663/0001209191-20-031663-index.htm
2019-12-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000121390019025087/0001213900-19-025087-index.htm
2020-03-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000121390020006823/0001213900-20-006823-index.htm
2020-04-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000121390020010018/0001213900-20-010018-index.htm
2020-08-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000121390020020809/0001213900-20-020809-index.htm
2020-11-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000121390020035462/0001213900-20-035462-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218007765/0001493152-18-007765-index.htm
2018-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218008253/0001493152-18-008253-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218008575/0001493152-18-008575-index.htm
2018-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218010415/0001493152-18-010415-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218011138/0001493152-18-011138-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315218011140/0001493152-18-011140-index.htm
2018-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218013520/0001493152-18-013520-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315218015410/0001493152-18-015410-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315218015417/0001493152-18-015417-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219000082/0001493152-19-000082-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315219000901/0001493152-19-000901-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219000956/0001493152-19-000956-index.htm
2019-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315219001023/0001493152-19-001023-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219001156/0001493152-19-001156-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219003129/0001493152-19-003129-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/0001493152-19-003143-index.htm
2019-03-12S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1595097/000149315219003206/0001493152-19-003206-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219004518/0001493152-19-004518-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219005015/0001493152-19-005015-index.htm
2019-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595097/000149315219005114/0001493152-19-005114-index.htm
2019-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1595097/000149315219005115/0001493152-19-005115-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219005599/0001493152-19-005599-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219006607/0001493152-19-006607-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315219006611/0001493152-19-006611-index.htm
2019-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219008125/0001493152-19-008125-index.htm
2019-06-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595097/000149315219009707/0001493152-19-009707-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219011831/0001493152-19-011831-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315219011835/0001493152-19-011835-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219016583/0001493152-19-016583-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315219016601/0001493152-19-016601-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315219018312/0001493152-19-018312-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220001701/0001493152-20-001701-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220001766/0001493152-20-001766-index.htm
2020-02-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220001838/0001493152-20-001838-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220003644/0001493152-20-003644-index.htm
2020-03-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220003662/0001493152-20-003662-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220003663/0001493152-20-003663-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220003772/0001493152-20-003772-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/0001493152-20-004077-index.htm
2020-03-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220004157/0001493152-20-004157-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220005602/0001493152-20-005602-index.htm
2020-04-07S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595097/000149315220005953/0001493152-20-005953-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220005955/0001493152-20-005955-index.htm
2020-04-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220006110/0001493152-20-006110-index.htm
2020-04-09DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1595097/000149315220006111/0001493152-20-006111-index.htm
2020-04-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220006836/0001493152-20-006836-index.htm
2020-04-24S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595097/000149315220007094/0001493152-20-007094-index.htm
2020-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595097/000149315220007096/0001493152-20-007096-index.htm
2020-04-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595097/000149315220007445/0001493152-20-007445-index.htm
2020-05-04424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220007596/0001493152-20-007596-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220008150/0001493152-20-008150-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220008248/0001493152-20-008248-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220009623/0001493152-20-009623-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220012800/0001493152-20-012800-index.htm
2020-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220012801/0001493152-20-012801-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595097/000149315220012802/0001493152-20-012802-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220014133/0001493152-20-014133-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220014810/0001493152-20-014810-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220014895/0001493152-20-014895-index.htm
2020-08-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220014902/0001493152-20-014902-index.htm
2020-08-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220014904/0001493152-20-014904-index.htm
2020-08-3110-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595097/000149315220017022/0001493152-20-017022-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220017365/0001493152-20-017365-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220017794/0001493152-20-017794-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220018325/0001493152-20-018325-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220018978/0001493152-20-018978-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595097/000149315220019126/0001493152-20-019126-index.htm
2018-10-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000161577418011405/0001615774-18-011405-index.htm
2019-02-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000161577419002673/0001615774-19-002673-index.htm
2019-04-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000161577419006505/0001615774-19-006505-index.htm
2019-06-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595097/000161577419009075/0001615774-19-009075-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1595097/999999999520001005/9999999995-20-001005-index.htm
2018-12-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1595097/999999999718009293/9999999997-18-009293-index.htm
2019-03-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1595097/999999999719000685/9999999997-19-000685-index.htm

Corbus Pharmaceuticals Holdings, Inc (CRBP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corbus Pharmaceuticals Holdings, Inc (CRBP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 173%
Institutional Ownership: 7549%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-15John Kenneth JenkinsDirectorBuy1,000.006.986,977.901,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019614/0001209191-19-019614-index.htm
2019-11-11Craig Stuart MillianChief Commercial OfficerBuy1,000.004.384,380.0010,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119055930/0001209191-19-055930-index.htm
2020-03-17Craig Stuart MillianChief Commercial OfficerBuy2,000.004.258,500.0012,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919120019954/0001209191-20-019954-index.htm
2018-05-15Barbara WhiteChief Medical OfficerBuy2,586.005.8715,174.39179,521.00https://www.sec.gov/Archives/edgar/data/1595097/000120919118030426/0001209191-18-030426-index.htm
2019-03-14Barbara WhiteChief Medical OfficerBuy4,638.006.4729,993.95184,159.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019374/0001209191-19-019374-index.htm
2019-05-17Barbara WhiteChief Medical OfficerBuy1,389.007.2010,000.80185,548.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119031229/0001209191-19-031229-index.htm
2019-08-12Barbara WhiteChief Medical OfficerBuy1,639.006.109,997.90187,187.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119045697/0001209191-19-045697-index.htm
2019-11-12Barbara WhiteChief Medical OfficerBuy3,424.004.3814,991.64190,611.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119056260/0001209191-19-056260-index.htm
2020-03-17Barbara WhiteChief Medical OfficerBuy15,606.003.6356,649.78206,217.00https://www.sec.gov/Archives/edgar/data/1595097/000120919120019914/0001209191-20-019914-index.htm
2018-11-14Mark TepperPresident and CSOBuy10,000.001.0010,000.002,110,400.00https://www.sec.gov/Archives/edgar/data/1595097/000120919118058931/0001209191-18-058931-index.htm
2019-08-12Robert Paul DiscordiaChief Operating OfficerBuy15,000.005.8687,894.0030,150.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119045442/0001209191-19-045442-index.htm
2019-11-11Robert Paul DiscordiaChief Operating OfficerBuy2,500.004.6211,558.5032,650.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119055918/0001209191-19-055918-index.htm
2019-03-14Sean F. MoranChief Financial OfficerBuy1,500.006.6710,005.00349,510.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019352/0001209191-19-019352-index.htm
2019-05-14Sean F. MoranChief Financial OfficerBuy100.007.12712.00349,610.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119029556/0001209191-19-029556-index.htm
2020-03-17Robert Paul DiscordiaChief Operating OfficerBuy2,840.003.5410,053.6035,490.00https://www.sec.gov/Archives/edgar/data/1595097/000120919120019931/0001209191-20-019931-index.htm
2019-03-14Craig Stuart MillianChief Commercial OfficerBuy5,000.006.8534,258.505,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019602/0001209191-19-019602-index.htm
2019-05-14Craig Stuart MillianChief Commercial OfficerBuy1,000.007.237,226.606,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119029852/0001209191-19-029852-index.htm
2019-03-14Yuval CohenChief Executive OfficerBuy1,530.006.499,929.7063,190.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/0001209191-19-019345-index.htm
2019-05-13Yuval CohenChief Executive OfficerBuy995.006.996,954.8564,185.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/0001209191-19-029514-index.htm
2019-08-12Yuval CohenChief Executive OfficerBuy1,175.006.067,115.8065,360.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/0001209191-19-045444-index.htm
2019-11-12Yuval CohenChief Executive OfficerBuy1,430.004.266,091.8066,790.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/0001209191-19-055941-index.htm
2019-03-15David P HochmanDirectorBuy2,000.006.9813,957.607,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119019885/0001209191-19-019885-index.htm
2020-03-17Yuval CohenChief Executive OfficerBuy4,300.003.4915,007.0071,090.00https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/0001209191-20-019502-index.htm
2019-08-12Craig Stuart MillianChief Commercial OfficerBuy1,500.006.009,000.007,500.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119045684/0001209191-19-045684-index.htm
2019-08-15Craig Stuart MillianChief Commercial OfficerBuy1,500.005.488,212.959,000.00https://www.sec.gov/Archives/edgar/data/1595097/000120919119046252/0001209191-19-046252-index.htm